|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：G797750 |
| 產(chǎn)品名稱：GSK 923295 |
| 產(chǎn)品CAS：1088965-37-0 |
| 規(guī)格含量：50mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
G797750 |
| 名稱: |
GSK 923295 |
| 別名: |
3-Chloro-N-[(1S)-2-[[2-(dimethylamino)acetyl]amino]-1-[[4-[8-[(1S)-1-hydroxyethyl]imidazo[1,2-a]pyridin-2-yl]phenyl]methyl]ethyl]-4-(1-methylethoxy)-benzamide; 3-Chloro-N-{(1S)-2-[(N,N-dimethylglycyl)amino]-1-[(4-{8-[(1S)-1-hydroxyethyl]imidazo[1,2-a]pyridin-2-yl}phenyl)methyl]ethyl}-4-[(1-methylethyl)oxy]benzamide; GSK 923295A |
| CAS號(hào): |
1088965-37-0 |
| 分子式: |
C??H??ClN?O? |
| 分子量: |
592.13 |
| 種類: |
Research Tools; |
| 應(yīng)用: |
GSK 923295 is the first potent, CENP-E-selective inhibitor that has been tested in Phase I clinical trials for treatment of Refractory Cancers. |
| 參考文獻(xiàn) |
|
|
|
|
?您的位置：
